Diabetes & Insulin Pharmacology MCQs (Part 5) | 10 High-Yield Questions for USMLE, NEET PG & NCLEX

Diabetes pharmacology MCQs with answers—Part 5. Test yourself with 10 challenging questions based on Chapter 41 of Katzung’s Basic & Clinical Pharmacology. This quiz reviews insulin first-pass clearance, sulfonylureas in renal impairment, pramlintide, SGLT2 inhibitors, pioglitazone, insulin injection technique, linagliptin, nateglinide, miglitol and acarbose. DON’T FAIL YOUR BOARDS—CAN YOU SCORE 10/10? Pause after each question, select the best answer and explain your reasoning before the solution appears. Every MCQ has a concise explanation connecting drug mechanisms, pharmacokinetics, adverse effects and patient-specific risks. This is Part 5 of the ZeeMed Academy Diabetes Pharmacology MCQ series. Questions 41–50 continue the exam-focused review from Parts 1–4. VIDEO CHAPTERS 00:00 Q41 Endogenous Insulin and First-Pass Clearance 00:30 Q42 Glipizide vs Glyburide in Renal Impairment 01:00 Q43 How Pramlintide Reduces Post-Meal Glucose 01:30 Q44 SGLT2 Inhibitors, Polyuria and Dizziness 02:00 Q45 Pioglitazone and Worsening Heart Failure 02:30 Q46 Which Receptor Does Pioglitazone Activate? 03:00 Q47 Insulin Injection-Site Lipohypertrophy 03:30 Q48 Linagliptin and Renal Dose Adjustment 04:00 Q49 Nateglinide Drug Class 04:30 Q50 Miglitol vs Acarbose Pharmacokinetics WHAT THIS QUIZ COVERS • Why the liver removes a large fraction of endogenous insulin during its first portal passage • Why glipizide is generally preferred over glyburide when a sulfonylurea is required in an older patient with renal impairment • How pramlintide suppresses meal-related glucagon and slows gastric emptying • Why SGLT2 inhibitors can cause polyuria, postural dizziness and volume contraction • How pioglitazone-associated fluid retention can precipitate or worsen heart failure • Activation of the nuclear receptor PPAR-gamma by pioglitazone • Recognition and prevention of insulin injection-site lipohypertrophy • Why linagliptin generally requires no renal dose adjustment • Identification of nateglinide as a D-phenylalanine derivative • The absorption difference between miglitol and acarbose WHO SHOULD WATCH? Designed for medical, pharmacy and nursing students, junior clinicians and candidates preparing for MBBS, MD, PharmD, BPharm, BSN, USMLE, NCLEX, NAPLEX, PLAB, MRCP, GPAT and university pharmacology examinations. Use this pharmacology practice test for active recall before lectures, tests and board-style examinations. It is useful for comparing drugs within the same class and choosing safer medicines for patients with renal impairment, heart failure or other clinical risks. HOW TO STUDY Attempt all 10 questions without notes and record your score. State your option and reasoning before the answer appears. Review every explanation, including questions you answered correctly but were uncertain about. Repeat the quiz after several days and compare your scores across Parts 1–5. RELATED KEYWORDS Diabetes pharmacology MCQs, pharmacology MCQs with answers, antidiabetic drugs MCQs, insulin pharmacology, Katzung pharmacology Chapter 41, endogenous insulin clearance, hepatic insulin extraction, glipizide renal impairment, glyburide hypoglycemia, pramlintide mechanism, SGLT2 inhibitor side effects, osmotic diuresis, pioglitazone heart failure, PPAR gamma, insulin lipohypertrophy, injection site rotation, linagliptin renal dosing, nateglinide mechanism, miglitol vs acarbose, USMLE pharmacology, NCLEX diabetes questions and NAPLEX practice questions. US and UK terms are included where relevant, including glyburide/glibenclamide and hypoglycemia/hypoglycaemia, supporting learners in the US, UK, India, Pakistan, Middle East and worldwide. REFERENCE Questions were developed from diabetes pharmacology material in Chapter 41 of Katzung’s Basic & Clinical Pharmacology. This independent educational quiz is not affiliated with, sponsored by or endorsed by the textbook’s authors, editors or publisher. Chapter numbering and recommendations may differ between editions. Consult your edition and current clinical guidelines or prescribing information for treatment, dosing and monitoring decisions. EDUCATIONAL DISCLAIMER This video is for education and examination revision only, not personal medical advice. Do not use it to diagnose, prescribe or change medication. Clinical decisions require current guidance, patient-specific assessment and qualified professional care. Subscribe to ZeeMed Academy for more diabetes pharmacology MCQs, insulin quizzes, antidiabetic drug questions and clinical challenges. Comment with your score out of 10 and tell us which question was most difficult. Avoid posting the answer in your first line so other learners can attempt the challenge without spoilers. #DiabetesPharmacology #PharmacologyMCQs #USMLE #ZeeMedAcademy